- Home
- CMRX vs SNCY Comparison
CMRX vs SNCY Comparison
Compare CMRX & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- SNCY
- Stock Information
- Founded
- CMRX 2000
- SNCY 1982
- Country
- CMRX United States
- SNCY United States
- Employees
- CMRX N/A
- SNCY N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- SNCY Air Freight/Delivery Services
- Sector
- CMRX Health Care
- SNCY Consumer Discretionary
- Exchange
- CMRX Nasdaq
- SNCY Nasdaq
- Market Cap
- CMRX 797.3M
- SNCY 670.1M
- IPO Year
- CMRX 2013
- SNCY 2021
- Fundamental
- Price
- CMRX $8.54
- SNCY $8.88
- Analyst Decision
- CMRX Hold
- SNCY Buy
- Analyst Count
- CMRX 4
- SNCY 7
- Target Price
- CMRX $8.51
- SNCY $17.71
- AVG Volume (30 Days)
- CMRX 2.0M
- SNCY 1.1M
- Earning Date
- CMRX 04-30-2025
- SNCY 05-05-2025
- Dividend Yield
- CMRX N/A
- SNCY N/A
- EPS Growth
- CMRX N/A
- SNCY N/A
- EPS
- CMRX N/A
- SNCY 0.96
- Revenue
- CMRX $212,000.00
- SNCY $1,075,739,000.00
- Revenue This Year
- CMRX $2,416.04
- SNCY $8.11
- Revenue Next Year
- CMRX $923.92
- SNCY $9.80
- P/E Ratio
- CMRX N/A
- SNCY $9.25
- Revenue Growth
- CMRX N/A
- SNCY 2.49
- 52 Week Low
- CMRX $0.75
- SNCY $8.88
- 52 Week High
- CMRX $8.55
- SNCY $18.59
- Technical
- Relative Strength Index (RSI)
- CMRX 80.86
- SNCY 32.13
- Support Level
- CMRX $8.50
- SNCY $9.41
- Resistance Level
- CMRX $8.55
- SNCY $10.65
- Average True Range (ATR)
- CMRX 0.02
- SNCY 0.98
- MACD
- CMRX -0.12
- SNCY -0.09
- Stochastic Oscillator
- CMRX 88.89
- SNCY 0.00
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.